Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Primary Biliary Cirrhosis
NCT00364819Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Jan 2007
- Primary completion
- Jul 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in primary biliary cholangitis (PBC), sponsored by University of California, Davis. Started Jan 2007; status: completed.
02
Drugs
rituximab
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT00364819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364819.